Coronary Artery Calcium, Exercise Tests, and CHD Outcome

This study has been completed.
Sponsor:
Collaborator:
Information provided by:
The Cooper Institute
ClinicalTrials.gov Identifier:
NCT00005562
First received: May 25, 2000
Last updated: March 12, 2014
Last verified: March 2014
  Purpose

To investigate coronary artery calcium (CAC), detected by electron beam computed tomography (EBCT), as a predictor of coronary heart disease (CHD) mortality and morbidity, stroke, and all-cause mortality in a historical cohort epidemiological study.


Condition
Cardiovascular Diseases
Coronary Disease
Cerebrovascular Disorders
Heart Diseases
Cerebrovascular Accident

Study Type: Observational

Resource links provided by NLM:


Further study details as provided by The Cooper Institute:

Study Start Date: September 1999
Study Completion Date: August 2006
Primary Completion Date: August 2006 (Final data collection date for primary outcome measure)
Detailed Description:

BACKGROUND:

Dramatic advances in medical and interventional treatment of clinically overt CHD have contributed substantially, perhaps predominately, to the decline over the past three decades in CHD mortality that has occurred despite relatively unchanged rates of myocardial infarction. By analogy, it is attractive to assume that substantial benefit could also be given to individuals with significant but asymptomatic coronary artery disease if only they could be accurately diagnosed. In this context, research to determine whether or not a non-invasive method like EBCT has sufficient independent predictive value for CHD events to play a useful role in this process has potentially considerable clinical and public health importance.

DESIGN NARRATIVE:

Follow-up of the 5,400 women and 12,600 men will be for an average of about 2.75 years with approximately 15,000 woman-years and 35,000 man-years of observations being available for analyses by June 30, 2000. An important strength of the study is the self-reported key health variables at baseline for all study participants. In addition, objective measures of blood pressure, total cholesterol, HDL- cholesterol, triglyceride, plasma glucose, resting and exercise electrocardiograms (ECG), maximal health rates, cardiorespiratory fitness, and other clinical and biochemical measurements are available for about half of the participants. CAC by EBCT has been associated with prevalent CHD and with incident CHD in recent small prospective studies. However, it is unclear whether CAC is predictive of MI or CHD deaths, because currently available studies had few individuals with evidence of hard CVD endpoints. The large cohort with CAC measurements provides the power to investigate an association between CAC and CHD morbidity, stroke, and all- cause mortality in terms of thresholds or dose-response effects. Exercise test results and measures of conventional CHD risk factors, including several health behaviors and biochemical markers, are available for about 50 percent of the participants. This will allow evaluation of the separate and independent predictive value of CAC and exercise test results and the combination of these two exposures in relation to study outcomes. Furthermore, CAC scores, exercise test results, and the presence of conventional risk factors will be used together to identify participants at the highest risk of developing CHD outcomes.

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

No eligibility criteria

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00005562

Sponsors and Collaborators
The Cooper Institute
Investigators
Investigator: Michael Lamonte Cooper Institute for Aerobics Research
  More Information

Publications:

ClinicalTrials.gov Identifier: NCT00005562     History of Changes
Other Study ID Numbers: 5108, R01HL062508
Study First Received: May 25, 2000
Last Updated: March 12, 2014
Health Authority: United States: Federal Government

Additional relevant MeSH terms:
Cardiovascular Diseases
Cerebrovascular Disorders
Coronary Disease
Coronary Artery Disease
Heart Diseases
Cerebral Infarction
Stroke
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Vascular Diseases
Myocardial Ischemia
Arteriosclerosis
Arterial Occlusive Diseases
Brain Infarction
Brain Ischemia

ClinicalTrials.gov processed this record on April 22, 2014